IDEX Corporation to Webcast Second Quarter 2026 Earnings Call

NORTHBROOK, Ill.–(BUSINESS WIRE)–IDEX Corporation (NYSE:IEX) announced today that it will release its second quarter 2026 results on Wednesday, July 29, 2026, prior to market open. An investor conference call and webcast will take place at 8:00 a.m. (CT) that same day with Chief Executive Officer and President Eric Ashleman and Senior Vice President and Chief Financial Officer Sean Gillen. The event and associated earnings presentation will be available via webcast in listen-only mode on the Company’s Investor Relations site at https://investors.idexcorp.com. To participate via telephone, please dial USA Toll-Free 1-833-461-5787 or International 1-585-542-9983 and use confirmation code 212572551. Telephone participants are asked to connect five minutes prior to the start of the conference call. A replay of the earnings call will be available via webcast on the Company’s website.

IDEX Tagline Blue Stacked Square %281%29
IDEX Tagline Blue Stacked Square %281%29

About IDEX

IDEX Corporation (NYSE: IEX), a global engineered products company, is comprised of three primary business segments – Health & Science Technologies, Fluid & Metering Technologies, and Fire & Safety / Diversified Products. Thousands of IDEX employees around the world design and manufacture highly engineered components and applied solutions that are vital to the advances of modern life and help IDEX live its purpose – Trusted Solutions, Improving Lives™. From satellite communications to water systems, from medical diagnostic components to emergency rescue tools and more, we collaborate with customers in the most critical industries to develop solutions that make the world better today and into the future. Founded in 1988, IDEX now includes more than 50 dynamic businesses around the world and manufacturing operations in more than 20 countries. Learn more about the impactful work we do at www.idexcorp.com.

Contacts

Investor Contact:
Jim Giannakouros, CFA
Vice President, Investor Relations
(847) 313-9506
[email protected]

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Stay up-to-date with the latest Newsletters, free of charge.